PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Previous studies have highlighted diverse mechanisms underlying the anti-NAFLD effects of flavonoids: Luteolin improves NAFLD by modulating the AMPK/PGC-1α pathway, restoring gut microbiota, and inhibiting inflammatory pathways such as TLR4/NF-κB [43,54,55].